effective phototherapy for neonatal jaundice
TRANSCRIPT
Introduction
• Phototherapy - mainstay of treatment unconj. Hyperbili.
• PT is effective in reducing excessive unconj. Hyperbili.
• drastically curtailed the use of ET• Phototherapy should be regarded as a
drug, with an appropriate dose and duration
PT – Indication
• The initiation and duration of PT decided by- total bilirubin values - an infant’s postnatal age - the potential risk for bilirubin neurotoxicity
PT – Indication ( ≥35 wk )
2004 AAP guideline
J Clin Neonatol. 2013
PT - Indication(≤ 35 wk )
The Mechanism Of Phototherapy
Advances in Neonatal Care • Vol. 11, No. 5S, 2011
Efficacy of PT DevicesDepends on - • Spectral qualities of the light source used
(wavelength range and peak)• Intensity of the light (irradiance)• Body surface area exposed by the irradiated
field or “footprint.”• Distance between the light and the infant’s
skin Advances in Neonatal Care • Vol. 11, No. 5S, 2011
Optimal Administration of PT – Practical Considerations
• Light source (wavelength) (nm)• Light irradiance (W·cm2·nm1)• Body surface area (cm2)• Continuity of therapy• Efficacy of intervention• Duration of therapy
Optimal Administration of PT Light source (wavelength) (nm)
Practice Considerations - Light source (nm)
• Recommendation - Wavelength spectrum in 460- 490-nm blue-green light region
• Imp. - Know the spectral output of the light source
Pediatrics 2011;128;e1046
Light source /Wavelength
• visible white light spectrum - 350 to 800 nm
• Bilirubin absorbs visible light most strongly in the blue region of the spectrum (~460 nm)
• the most effective light in vivo is probably in the blue-to-green region (460–490 nm).
Light source /Wavelength Commercial Light Sources • Fluorescent
- cool white daylight - blue [B]- special blue [BB] - Turquoise and green
• narrow-band special blue bulbs - TL52/20W [Phillips] or - F20T12/BB [GE]- More effective
Light source /Wavelength
• Special blue (BB) fluorescent lights - not be confused with white lights painted blue or covered with blue plastic sheaths
• Unless specified otherwise, plastic covers or optical filters need to be used to remove potentially harmful UV light.
Light source /Wavelength • commercial compact fluorescent-tube
light (CFL) sources • LEDs of narrow spectral bandwidth
- used as over- and under-the-body devices.• Fiberoptic - pads, blankets• Halogen - spotlights
Light source /Wavelength
• High intensity gallium nitride LEDs with emission within the 460- to 490-nm regionsare as effective as CFL / Conventional - lower heat output, - low infrared emission, and - no ultraviolet emission- a longer lifetime (20 000 hours)
Adv Biomed Res. 2012; 1: 51.
Optimal Administration of PTLight Irradiance
Light Irradiance (intensity )• Light intensity or energy output is defined by
irradiance• number of photons (spectral energy) that are
delivered per unit area (cm2) of exposed skin• The dose of phototherapy - measure of the
irradiance delivered for a specific duration andadjusted to the exposed body surface area (µW·cm2·nm)
Light Irradiance
• Recommendation : Use optimal irradiance• The recommended minimal irradiance levels
are 8– 12 µW⁄cm2 ⁄nm• for intensive PT ≥30 W·cm2·nm within the
460- to 490-nm waveband• Imp: Ensure uniformity over the light footprint
area
Pediatrics 2011;128;e1046
Light Irradiance• Devices that emit lower irradiance may be
supplemented with auxiliary devices • bringing the light source close to the infant
increases irradiance - Caution : not be done with halogen lights
The ideal distance and orientation of the light source should be maintained according to the manufacturer’s recommendations
• The irradiance of all lamps decreases with use
Optimal Administration of PT Body surface area (cm2)
Practice Considerations – Body surface area (cm2)
• Recommendation : Expose maximal skin area
• Imp : Reduce blocking of light
Pediatrics 2011;128;e1046
Body Surface Area• Complete (100%) exposure of the total body
surface to light is impractical and limited by use of eye masks and diapers
• Circumferential illumination achieves exposure of approximately 80% of the total body surface.
• In clinical practice, exposure is usually planar (ventral or dorsal)
• Approximately 35% of the total body surface is exposed with either method
Body Surface Area• Changing the infant’s posture every 2 to 3 hrs
-maximizes the area exposed to light• Exposed body surface area treated rather than
the number of devices (double, triple, etc) used clinically more important
• Physical obstruction of light by equipment decreases the exposed skin surface area
Pediatrics 2011;128;e1046
Body Surface Area• Combining several devices, will increase the
surface area exposed.- placing a light source beneath the infant
• reflecting material around the incubator or radiant warmer bed useful
Pediatrics 2011;128;e1046
Imp Factors in the Efficacy of PT
N Engl J Med 2008;358:920-8.
Optimal Administration of PT Continuity of therapy
Practice Considerations
• Continuity of therapy as far as possible • Recommendation : Briefly interrupt for
feeding, parental bonding, nursing care• Imp : After confirmation of adequate
bilirubin concentration decrease
Pediatrics 2011;128;e1046
Optimal Administration of PT Efficacy of intervention
Practice Considerations
• Efficacy of intervention • Recommendation : Periodically measure
rate of response in bilirubin load reduction
• Imp : to look at , Degree of total serum bilirubin concentration decrease
Pediatrics 2011;128;e1046
Efficacy of intervention - Rate of Response
• The clinical response depends on the rates of bilirubin production enterohepatic circulationbilirubin eliminationthe degree of tissue bilirubin deposition the rates of the photochemical reactions of
bilirubin.
Efficacy of intervention - Rate of Response
• The clinical impact of phototherapy should be evident within 4 to 6 hours
• Decrease of more than 2 mg/dL in serum bilirubin concentration.
• Periodicity of serial measurements is based on clinical judgment.
Optimal Administration of PT
• Practice Considerations - Duration of therapy• Recommendation : Discontinue at desired
bilirubin threshold, be aware of possible rebound increase
• Imp : Serial bilirubin measurements based on rate of decrease
Pediatrics 2011;128;e1046
Failure of PT • an inability to observe a decline in bilirubin of
1-2 mg/dL after 4-6 hours and/or • to keep the bilirubin below the BET level. • ? Consider intensive PT
• No Role of prophylactic PT in preterm babies
NNFguidelines2010
Stopping Phototherapy• serum bilirubin level has fallen below 2mgs/dL
lower than threshold• Check for rebound Consider if prematurity, direct Coombs test
positivity, and those treated < 72 hours. Not indicated if, non-hemolytic etiology and an
early follow up after discharge
NNFguidelines2010
Phototherapy Infants ≤ 35 weeks GA
• Generally used in a prophylactic mode• goal - to prevent further elevation TSB• at least in infants with BW<750 g, initiate
phototherapy at lower irradiance levels• increase irradiance levels, or increase the
surface area of the infant exposed to PT, if the TSB continues to rise
MJ Maisels et al , 2012
Measuring Light Irradiance
• Visual estimations of brightness & use of ordinary photometric/colorimetric light meters are inappropriate
• measured with a radiometer (W·cm2) or spectroradiometer (W·cm2·nm1) over a given wavelength band.
Measuring Light Irradiance
• Irradiance should be measured at several sites on the infant’s body surface
• different radiometers may show different values for the same light source
• Use manufacturer recommended
Measuring Light Irradiance
• For improving the application of effective phototherapy, need to develop an affordable, user-friendly, handheld, universal irradiance meter which accurately measures irradiance delivered by all types of phototherapy light sources.
Vreman HJ, Indian Pediatr, 2010
Safety And Protective Measures• Four decades of neonatal phototherapy use
- no serious adverse clinical effects• Ensure adequate hydration, nutrition, and
temperature control.• Devices - Must meet electrical and fire hazard
safety standards (IEC )
Safety And Protective Measures• Eye patches - Purulent eye discharge and
conjunctivitis in term infants with prolonged use
• Use of diapers: Diapers may be used for hygiene but are not essential.
• PT Contraindication - infants with congenital porphyria or those treated with photosensitizing drugs.
PT- Sunlight • Sunlight will lower the serum bilirubin level,
the practical difficulties involved in safely exposing a naked newborn to the sun either inside or outside (and avoiding sunburn) preclude the use of sunlight as a reliable therapeutic tool.
Transcutaneous Bilirubinometry (TcB)
Pathak U et al, IJP, 2013
Key Messages 1• Use special blue tubes or LED light source with
output in blue-green spectrum• If special blue fluorescent tubes are used, bring
tubes as close to infant as possible to increase irradiance
• For intensive PT, expose maximum surface area of infant to PT.
• Place lights above and fiber-optic pad or special blue fluorescent tubes* below the infant.
Key Messages 2• Intensive PT requires >30 μW/cm2 per
nm.• For maximum exposure, line sides of
bassinet, warmer bed, or incubator with aluminum foil.
• Use intensive PT for higher TSB levels. • Periodically measure rate of response• Monitor Irradiance
Thank you